Brown Advisory’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.45M Buy
41,694
+18,745
+82% +$2.27M 0.01% 571
2026
Q1
$3.75M Buy
22,949
+2,960
+15% +$455K 0.01% 577
2025
Q4
$3.48M Sell
19,989
-6,120
-23% -$1.12M ﹤0.01% 596
2025
Q3
$3.76M Sell
26,109
-553,737
-95% -$67.8M ﹤0.01% 566
2025
Q2
$58.4M Sell
579,846
-92,604
-14% -$7.08M 0.08% 177
2025
Q1
$51.3M Buy
672,450
+9,453
+1% +$723K 0.07% 183
2024
Q4
$45.8M Buy
+662,997
New +$47.7M 0.06% 223

Other funds holding INSM

Brown Advisory's INSM Position: Q2 2026 in Review

Brown Advisory increased its Insmed (INSM) stake by 82% in Q2 2026, buying an estimated $2.27M and bringing the position to 41,694 shares worth $4.45M. The position accounts for 0.01% of the portfolio, ranked #571.

Brown Advisory first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $58.4M in Q2 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Brown Advisory held 41,694 shares of Insmed worth $4.45M as of Q2 2026.
  • Brown Advisory bought 18,745 Insmed shares in Q2 2026, an estimated $2.27M.
  • Insmed made up 0.01% of Brown Advisory's portfolio in Q2 2026, its #571 holding.
  • Brown Advisory first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • Brown Advisory's Insmed position peaked at $58.4M in Q2 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.